Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020194034 - NANOPARTICLE OF CHITOSAN AND CYCLODEXTRIN CONTAINING ENCAPSULATED INTERFERON AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT

Publication Number WO/2020/194034
Publication Date 01.10.2020
International Application No. PCT/IB2019/052510
International Filing Date 27.03.2019
IPC
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 9/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
12Aerosols; Foams
A61K 9/51 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules
51Nanocapsules
A61K 38/21 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
21Interferons
A61P 25/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 31/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
CPC
A61K 38/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
21Interferons ; [IFN]
A61K 9/0043
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0043Nose
A61K 9/0073
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
A61K 9/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
12Aerosols; Foams
A61K 9/5161
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules ; having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
51Nanocapsules; Nanoparticles;
5107Excipients; Inactive ingredients
513Organic macromolecular compounds; Dendrimers
5161Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
A61P 25/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants
  • UNIVERSIDAD DE CHILE [CL]/[CL]
Inventors
  • NAVES PICHUANTE, Rodrigo Antonio
  • GONZÁLEZ LÓPEZ, Luis Fernando
  • OYARZÚN AMPUERO, Felipe Andrés
Agents
  • MATTAR MARTINEZ, Ignacio
Priority Data
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NANOPARTICLE OF CHITOSAN AND CYCLODEXTRIN CONTAINING ENCAPSULATED INTERFERON AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
(FR) NANOPARTICULE DE CHITOSANE ET DE CYCLODEXTRINE CONTENANT UN INTERFÉRON ENCAPSULÉ ET COMPOSITIONS PHARMACEUTIQUES LA CONTENANT
Abstract
(EN)
The present invention refers to nanoparticles containing interferon encapsulated with chitosan and cyclodextrin and a pharmaceutical composition containing them, specially designed to be used by a non-invasive alternative administration route to a patient, in order to improve the therapeutic efficiency of treatments with interferons, particularly those needing that said molecule reaches the target organ of interest directly.
(FR)
La présente invention concerne des nanoparticules contenant un interféron encapsulé avec du chitosane et de la cyclodextrine et une composition pharmaceutique les contenant, spécialement conçues pour être utilisées par une voie d'administration alternative non invasive à un patient, afin d'améliorer l'efficacité thérapeutique de traitements avec des interférons, en particulier ceux nécessitant que ladite molécule atteigne l'organe d'intérêt cible directement.
Latest bibliographic data on file with the International Bureau